Navigation Links
Dr. Szczepan Baran Appointed to Board of Directors at Americans for Medical Progress
Date:9/30/2013

Winston Salem, NC (PRWEB) September 30, 2013

Dr. Szczepan Baran, President of the Veterinary Bioscience Institute (VBI, http://www.vetbiotech.com) was recently added to the Board of Directors for Americans for Medical Progress (AMP, http://www.amprogress.org).

The Americans for Medical Progress organization is a group of scientists, veterinarians and physicians who support the humane and ethical use of animals in research. The goal of the organization is to promote outreach to other medical professionals as well as the public on dispelling the myths surrounding animal research. In addition, they discuss the benefits and accomplishments that have been made thanks to animal research.

“I am very honored to be chosen to be a member of the board of directors for this very important organization,” states Dr. Baran. “The goals of Americans for Medical Progress are very similar to those of the Veterinary Bioscience Institute. We both heavily promote and support the 3R’s of research [Reduction, Refinement and Replacement of animals in research], but we also know that without the benefits of being able to utilize animals in research, we would not have a fraction of the drugs, medical devices or therapies that we now have to offer better, longer, more disease-free lives for countless humans.”

“Having Dr. Baran sit on the Board of Directors of AMP is a further validation of his work in the laboratory animal community,” states James Kehler, Vice President of Global Business Development for VBI. “I am very excited to see how his contributions continue to shape the future of laboratory animal medicine.”

The Veterinary Bioscience Institute provides continuing education and training to the life sciences community. They have revolutionized surgical training by validating knowledge transfer through an online platform. They have successfully implemented a hybrid model of online learning complemented with hands on training that directly promotes and upholds the tenets of the 3 R’s of animal use in research.

Read the full story at http://www.prweb.com/releases/2013/9/prweb10997041.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York
2. VBI’s Dr. Szczepan Baran is an Invited Speaker at the Swiss Laboratory Animal (SGV) National Meeting
3. V. Suzanne Klimberg, M.D. Appointed Medical Director of Ascendant Diagnostics™
4. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
5. Quorum Review IRB Board Chair Appointed to SACHRP
6. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
7. ClearPath Workforce Management CEO Appointed Co-chair of Northern California Leadership Forum for Woman Owned Business Alliance
8. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
9. Gregory Raupp Appointed Director of MacroTechnology Works at Arizona State University to Advance Flexible Electronics and Manufacturing
10. Janet Kreizman Appointed Chief Executive Officer of AACC
11. Infotrieve Appointed to EContent 100
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... process optimization firm for the life sciences and healthcare industries, announces a presentation ... San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):